Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaiken, R. L.
Right arrow Articles by Lebovitz, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaiken, R. L.
Right arrow Articles by Lebovitz, H. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 21, Issue 12 2129-2134, Copyright © 1998 by American Diabetes Association


ARTICLES

Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data

RL Chaiken, M Eckert-Norton, M Bard, MA Banerji, J Palmisano, I Sachimechi and HE Lebovitz
Division of Endocrinology and Metabolism, State University of New York-Health Science Center at Brooklyn 11203, USA.

OBJECTIVE: Hyperfiltration may play a role in the development of diabetic nephropathy. African-American patients with diabetes have more than a fourfold increase in end-stage renal disease. The purpose of this study is to evaluate the impact of hyperfiltration on renal function in African-American patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: Renal function of 194 African-American patients with diagnosed type 2 diabetes from 1 month to 36 years was assessed by studies of isotopic glomerular filtration rate (GFR), serum creatinine, creatinine clearance, and 24-h urinary albumin excretion rates. Thirty-four patients with a duration of diagnosed type 2 diabetes from 1 month to 10 years were found to have hyperfiltration (GFR > or = 140 ml.min-1.1.73 m-2). Fifteen of these patients received longitudinal follow-up of renal function for as long as 15 years after the initial study. RESULTS: Hyperfiltration is present in 15 (36%) of 42 patients whose duration of diagnosed type 2 diabetes is < 1 year, and it persists for up to 10 years in 14-20% of patients with diagnosed type 2 diabetes. Patients with hyperfiltration are younger than their counterparts without hyperfiltration when matched for duration of diagnosed diabetes. When followed over time, those patients with hyperfiltration were not more likely to develop impaired renal function as measured by GFR or creatinine clearance. CONCLUSIONS: Hyperfiltration does not identify patients at risk for deterioration in renal function.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
R. M. Foutz, P. R. Grimm, and S. C. Sansom
Insulin increases the activity of mesangial BK channels through MAPK signaling
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1465 - F1472.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. L. Caramori, P. Fioretto, and M. Mauer
Enhancing the Predictive Value of Urinary Albumin for Diabetic Nephropathy
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 339 - 352.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Murussi, P. Baglio, J. L. Gross, and S. P. Silveiro
Risk Factors for Microalbuminuria and Macroalbuminuria in Type 2 Diabetic Patients: A 9-year follow-up study
Diabetes Care, June 1, 2002; 25(6): 1101 - 1103.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1998 by the American Diabetes Association.